Federal IT & Cybersecurity Contracts — June 12, 2026

SAIC secured a $290.8M cost-plus award fee delivery order from GSA for EPA end-user support, but the total outlay is -$1.4M, suggesting possible funding adjustments or early-stage underperformance. The contract ended in 2022, so no current revenue impact.

Peraton Enterprise Solutions LLC won a $121.6M firm-fixed-price BPA call from GSA for IT and telecom application development support. The fixed-price structure shifts cost overrun risk to Peraton, but the labor-based services are lower risk. The contract runs through June 2026 with potential extension to December 2026.

CTIS, INC., a small business, won a $85.6M cost-plus-fixed-fee delivery order from NIH NCI for IT and application development support. With $61.1M already outlaid, the contract is well into execution, reducing funding uncertainty. Direct investment implications are limited as CTIS is private.

SAIC's $290.8M GSA contract shows a negative outlay of -$1.4M, which may indicate past underperformance, funding clawbacks, or accounting errors. While the contract ended in 2022, it could signal execution risk on similar future awards.

All three contracts are civilian-agency awards (GSA and HHS), with zero defense exposure. This concentration in non-defense IT support may leave investors exposed to civilian budget volatility, especially under continuing resolutions that affect GSA and NIH funding.

All three contracts were awarded under full and open competition with no set-asides, meaning SAIC, Peraton, and CTIS won against other large competitors. This signals market strength but also means no preferential treatment, making re-competes vulnerable to displacement.

Peraton's $121.6M BPA call from GSA FAS for IT application development support could expand if options are exercised, increasing total value from $121.6M to $140.3M, signaling continued demand for legacy system modernization.

CTIS's $85.6M NIH NCI contract for cancer informatics has a potential three-month extension and options up to $96.5M, providing a stable revenue stream. If CTIS is acquired or goes public, this contract would be a key asset for investors.

No defense contracts were awarded in this digest, but SAIC and Peraton have significant defense portfolios. Investors should watch for defense IT modernization awards from DOD that could complement these civilian wins and diversify revenue.

All three contracts involve IT support or application development for civilian agencies (GSA, EPA, NIH), totaling $498.1M. This underscores stable demand for IT modernization in non-defense sectors, particularly for legacy system upgrades and health IT.

SAIC and CTIS won cost-plus contracts ($290.8M and $85.6M), which reduce profit risk, while Peraton's $121.6M fixed-price contract shifts cost overrun risk to the contractor. This mix highlights the importance of contract type in assessing margin stability.

{"entity"=>"Science Applications International Corporation", "reason"=>"SAIC's $290.8M GSA contract for EPA support ended in 2022, but the negative outlay (-$1.4M) warrants monitoring for follow-on wins or performance issues.", "trigger"=>"Re-compete announcement for EPA end-user support or new GSA FEDSIM awards"}

{"entity"=>"Peraton Enterprise Solutions LLC / Veritas Capital", "reason"=>"Peraton's $121.6M fixed-price BPA call runs through June 2026 with potential extension to December 2026. Option exercise or re-compete will signal demand for GSA IT modernization.", "trigger"=>"Option exercise by GSA FAS or re-compete announcement for similar IT application development services"}

{"entity"=>"CTIS, INC.", "reason"=>"CTIS's $85.6M NIH contract is well into execution ($61.1M outlaid), but as a private small business, any acquisition or IPO would create a public investment vehicle.", "trigger"=>"Acquisition announcement or IPO filing by CTIS"}